Given the evidence that Ang-(1–7) treatment is efficient in the treatment of MetS and that these benefits may occur through NO, here we studied whether the addition of L-Arginine in the N-terminal portion of Ang-(1–7), A-1317 compound, could enhance the beneficial effect observed by Ang-(1–7) in the already established MetS. The gene discussed is ANG; the disease is metabolic syndrome.